Table 3. A summary of descriptive information ofand study quality by outcome.
Buruli Ulcer n = 3 | CLM n = 1 | Leptospirosis n = 7 | Strongyloidiasis n = 4 | Any STH infection n = 11 | Hookworm infection n = 17 | Podoconiosis n = 6 | Tungiasis n = 4 | ||
Descriptive information | |||||||||
Median sample size (range) | 230 (136–232) | 126 | 276 (60–1169) | 30 (152–492) | 330 (59–1890) | 1324 (118–5291) | 1284 (416–129959) | 441 (147–557) | |
Median % of cases | 33 | 17 | 36 | 12 | 46 | 10 | 28 | 53 | |
Median age | Cases | 12 | 37 | 32 | 22 | 15 | 17 | 38 | 27 |
Without disease | 13 | 41 | 35 | 22 | 31 | 11 | 38 | 26 | |
Median % of females | Cases | 50 | + | 40 | 30 | 70 | 30 | 50 | 50 |
Without disease | 50 | + | 50 | 60 | 80 | 50 | 40 | 60 | |
Study quality | |||||||||
Number with cross-sectional survey design (%) | 0 (0) | 1 (100) | 4 (57) | 3 (75) | 10 (91) | 14 (82) | 5 (83) | 3 (75) | |
Footwear measured | By self-report | 3 (100) | 1 (100) | 7 (100) | 4 (100) | 10 (91) | 14 (82) | 5 (83) | 3 (75) |
By observation | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (9) | 3 (18) | 1 (17) | 1 (25) | |
Were the following items reported? (%) | Study population | 3 (100) | 1 (100) | 7 (100) | 4 (100) | 11 (100) | 17 (100) | 6 (100) | 4 (100) |
Selection of participants | 2 (67) | 1 (100) | 5 (71) | 3 (75) | 5 (45) | 14 (82) | 4 (67) | 4 (100) | |
Sample size/power calculation | 1 (33) | 1 (100) | 2 (29) | 2 (50) | 4 (36) | 4 (24) | 2 (33) | 3 (75) | |
Outcome and exposure measurement | 3 (100) | 1 (100) | 7 (100) | 4 (100) | 9 (82) | 15 (88) | 5 (83) | 3 (75) | |
Adjusted estimates for confounding | 3 (100) | 0 (0) | 5 (71) | 3 (75) | 4 (36) | 11 (65) | 3 (50) | 3 (75) |
+Missing data.